Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Feng

Showing results (1351-1360 of 2,038) with videos related to

Pageof 204
Sort By:
Cancer|December 4, 2019
Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012Santino S Butler, Vinayak Muralidhar, Shuang G Zhao, et al.
Nature Communications|August 30, 2019
Author Correction: Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanismsNima C Emami, Linda Kachuri, Travis J Meyers, et al.
Molecular Cancer Therapeutics|August 24, 2022
PLX038: A Long-Acting Topoisomerase I Inhibitor With Robust Antitumor Activity in ATM-Deficient Tumors and Potent Synergy With PARP InhibitorsAnish Thomas, Shaun D Fontaine, Morgan E Diolaiti, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|June 26, 2018
[Relationship between the HBsAg-positive infection status of mothers and the non/low-response to hepatitis B vaccine of their infants]Z Q Yang, H Y Hao, X H Shi, et al.
Wei Sheng Yan Jiu = Journal of Hygiene Research|January 1, 1997
[Environmental pollution, human exposure and its health effect of sodium pentachlorophenate in schistosomiasis prevalent area]X Zheng, Y Feng, X Jiang, et al.
Molecular Therapy. Methods & Clinical Development|March 23, 2023
Immunosuppression reduces rAAV2.5T neutralizing antibodies that limit efficacy following repeat dosing to ferret lungsYinghua Tang, Shahab Fakhari, Eric D Huntemann, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|September 15, 2017
[Comparison of antibody persistence after primary immunization with 5 μg and 10 μg recombinant hepatitis B vaccine among newborns with normal and high response: a five-year following-up]L Zhang, W Zhang, J J Lyu, et al.
Radiation Oncology (London, England)|July 10, 2013
A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomyWilliam C Jackson, Skyler B Johnson, Darren Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 26, 2022
[Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors]W J Zhu, H H Zhu, Y T Liu, et al.
Urologic Oncology|May 8, 2019
The current state of randomized clinical trial evidence for prostate brachytherapyRobert T Dess, Payal D Soni, William C Jackson, et al.
Pageof 204

Showing results (1351-1360 of 2,038) with videos related to

Sort By:
Pageof 204
Cancer|December 4, 2019
Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012Santino S Butler, Vinayak Muralidhar, Shuang G Zhao, et al.
Nature Communications|August 30, 2019
Author Correction: Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanismsNima C Emami, Linda Kachuri, Travis J Meyers, et al.
Molecular Cancer Therapeutics|August 24, 2022
PLX038: A Long-Acting Topoisomerase I Inhibitor With Robust Antitumor Activity in ATM-Deficient Tumors and Potent Synergy With PARP InhibitorsAnish Thomas, Shaun D Fontaine, Morgan E Diolaiti, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|June 26, 2018
[Relationship between the HBsAg-positive infection status of mothers and the non/low-response to hepatitis B vaccine of their infants]Z Q Yang, H Y Hao, X H Shi, et al.
Wei Sheng Yan Jiu = Journal of Hygiene Research|January 1, 1997
[Environmental pollution, human exposure and its health effect of sodium pentachlorophenate in schistosomiasis prevalent area]X Zheng, Y Feng, X Jiang, et al.
Molecular Therapy. Methods & Clinical Development|March 23, 2023
Immunosuppression reduces rAAV2.5T neutralizing antibodies that limit efficacy following repeat dosing to ferret lungsYinghua Tang, Shahab Fakhari, Eric D Huntemann, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|September 15, 2017
[Comparison of antibody persistence after primary immunization with 5 μg and 10 μg recombinant hepatitis B vaccine among newborns with normal and high response: a five-year following-up]L Zhang, W Zhang, J J Lyu, et al.
Radiation Oncology (London, England)|July 10, 2013
A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomyWilliam C Jackson, Skyler B Johnson, Darren Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 26, 2022
[Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors]W J Zhu, H H Zhu, Y T Liu, et al.
Urologic Oncology|May 8, 2019
The current state of randomized clinical trial evidence for prostate brachytherapyRobert T Dess, Payal D Soni, William C Jackson, et al.
Pageof 204